JP2022124985A

JP2022124985A - Pneumonia therapeutic drugs

Info

Publication number: JP2022124985A
Application number: JP2021080660A
Authority: JP
Inventors: 均石井; Hitoshi Ishii
Original assignee: Individual
Current assignee: Individual
Priority date: 2021-02-16
Filing date: 2021-02-16
Publication date: 2022-08-26

Abstract

To provide a therapeutic drug for pneumonia for which there is no effective therapeutic drug.SOLUTION: A denaturant is introduced into the human body to treat pneumonia by destroying the DNA and RNA of bacteria and viruses that have invaded the body to prevent their growth. Another effective method is to administer to the human body an alveolar-targeted modifying agent comprising a liposomal drug as an active ingredient.SELECTED DRAWING: None

Description

本発明は、肺炎治療薬に関する。The present invention relates to a therapeutic drug for pneumonia.

肺炎を根本的に治療する薬がない。There is no drug that can cure pneumonia.

肺炎治療薬を提供することを目的とする。The purpose is to provide a drug for treating pneumonia.

本発明の目的を達成するため、次の構成を採用する。
肺炎とは、主に細菌やウイルスに感染することにより、肺の中を通る気管支のさらに先にある肺胞という部位が炎症を起こす病気である。
変性剤を人体に投入することにより、肺炎の原因である身体に侵入した細菌やウイルスのＤＮＡとＲＮＡを壊すことにより増殖を防ぎ、肺炎の治療をする。
細菌、ウイルス、などの肺炎の病原体は、核酸を持っている。
核酸とは、ＤＮＡとＲＮＡのことである。
ＤＮＡとＲＮＡは塩基間で水素結合しているが、変性剤を加えてアルカリ性にすると、水素イオンを放出するため変性し、ＤＮＡとＲＮＡの水素結合が壊れる。
変性剤を加えてＤＮＡとＲＮＡを壊すことにより、細菌、ウイルスの増殖を防ぐことができるため、変性剤という肺炎治療薬となる。
肺胞を標的とする変性剤を有効成分とするリポソーム医薬品として、人体に投与する方法も有効である。In order to achieve the objects of the present invention, the following configuration is adopted.
Pneumonia is a disease that causes inflammation in the alveoli, which are located beyond the bronchi that pass through the lungs, mainly due to infection with bacteria or viruses.
By injecting a denaturing agent into the human body, the DNA and RNA of bacteria and viruses that cause pneumonia invading the body are destroyed, thereby preventing their growth and treating pneumonia.
Pneumonia pathogens, such as bacteria and viruses, carry nucleic acids.
Nucleic acids refer to DNA and RNA.
Although DNA and RNA are hydrogen-bonded between bases, when a denaturing agent is added to make them alkaline, hydrogen ions are released and they are denatured, breaking the hydrogen bond between DNA and RNA.
By adding a denaturant to destroy DNA and RNA, it is possible to prevent the growth of bacteria and viruses, so it becomes a pneumonia remedy called a denaturant.
A method of administering to the human body as a liposome drug containing a modifying agent targeting alveoli as an active ingredient is also effective.

変性剤という肺炎の治療薬を人体に投与することにより、肺炎を治療する。
代表的な変性剤は、尿素薬がある。Pneumonia is treated by administering a pneumonia remedy called a denaturant to the human body.
A representative denaturant is a urea drug.

変性剤という肺炎の治療薬を飲み薬として飲むか、注射により投与する。
肺胞を標的とする変性剤を有効成分とするリポソーム医薬品として、人体に投与する方法も有効である。
代表的な変性剤は、尿素薬がある。A pneumonia remedy called a denaturant is taken as an oral medicine or given by injection.
A method of administering to the human body as a liposome drug containing a modifying agent targeting alveoli as an active ingredient is also effective.
A representative denaturant is a urea drug.

Claims

As a method of treating pneumonia, administering a denaturing agent to the human body causes denaturation and destroys the DNA and RNA of the bacteria and viruses that cause pneumonia that have invaded the body, thereby preventing their growth and treating pneumonia. A remedy for pneumonia called a denaturing agent.